Published online Nov 24, 2026. doi: 10.5306/wjco.124859
Revised: August 1, 2026
Accepted: October 28, 2026
Published online: November 24, 2026
Processing time: 145 Days and 8.8 Hours
Myelolipoma is an extremely rare benign tumor composed of mature adipose tissue and hematopoietic elements. Its non-specific clinical presentation and imaging characteristics make preoperative diagnosis difficult, and it may be misdiagnosed as other fat-containing hepatic tumors, particularly hepatic angiomyolipoma. The tissue origin and pathogenesis of hepatic myelolipoma remain unclear. This report presents a rare case of an ectopic adrenal myelo
A 61-year-old woman presented with intermittent right upper abdominal pain for more than 2 months. Contrast-enhanced computed tomography showed a 6.2 cm × 4.2 cm fat-containing mass in the right posterior liver adjacent to the right adrenal gland. Magnetic resonance imaging demonstrated marked signal loss on opposed-phase images, mild delayed enhancement, and hypointensity in the hepatobiliary phase. Hepatic angiomyolipoma was suspected preoperatively. Given the patient’s symptoms and the lesion’s size (> 6 cm), laparoscopic local resection of the right posterior liver was performed. Histopathological exa
Ectopic adrenal myelolipoma should be considered in the differential diagnosis of fat-containing lesions at the hepatic-adrenal interface.
Core Tip: Ectopic adrenal myelolipoma involving the liver is exceptionally rare and may closely mimic hepatic angiomyolipoma on preoperative imaging. This case demonstrates the value of three-dimensional reconstruction for delineating the anatomical relationship among the mass, liver, and adrenal gland. Histopathological examination of adrenal tissue within the tumor capsule and hepatic tissue outside the capsule supported an ectopic adrenal origin. Therefore, ectopic adrenal myelolipoma should be considered in the differential diagnosis of fat-containing lesions at the hepatic-adrenal interface, helping to prevent misdiagnosis and inform appropriate surgical management.
- Citation: Su CS, Zhu XY, Li H, Zhang SG. Ectopic adrenal myelolipoma at the hepatic-adrenal interface mimicking hepatic angiomyolipoma: A case report. World J Clin Oncol 2026; 17(11): 124859
- URL: https://www.wjgnet.com/2218-4333/full/v17/i11/124859.htm
- DOI: https://dx.doi.org/10.5306/wjco.124859
Myelolipoma is a rare and nonfunctioning benign tumor that is prevalent in people aged 40-55 years, with no significant difference in incidence between sexes[1]. Myelolipoma usually has no specific clinical symptoms and is usually detected incidentally on imaging or during physical examination. Myelolipomas are generally round or oval and most frequently arise in the right adrenal gland. They may also occur at extra-adrenal sites, including the retroperitoneum, spleen, lungs, and liver[2,3]. To the best of our knowledge, only one case of coexisting myelolipoma of the liver and adrenal gland has been reported; however, the report did not provide insight into the tissue origin of hepatic myelolipoma (HM)[4]. This report provides imaging and histopathological evidence supporting an ectopic adrenal origin for a case of myelolipoma involving the liver.
A 61-year-old woman presented to the hospital with complaints of intermittent right upper abdominal pain that had persisted for more than 2 months.
The pain developed without an obvious precipitating factor, occurred intermittently, and improved with rest. She reported no fever, nausea, or vomiting.
The patient had a history of asthma for more than 50 years and was taking oral salbutamol sulfate; however, the dose and administration frequency were unavailable in the archived record. She had no history of hypertension, diabetes mellitus, viral hepatitis, cardiovascular or cerebrovascular disease, previous surgery, or food or drug allergies.
The patient did not smoke or consume alcohol and reported no family history of hereditary disease or malignancy.
On admission, her body temperature was 36.5 °C, pulse rate was 80 beats/minute, respiratory rate was 20 breaths/minute, and blood pressure was 140 mmHg/90 mmHg. The abdomen was flat and soft, with tenderness and pain in the right upper quadrant, but no guarding or rebound tenderness. Murphy’s sign was negative. Neither the liver nor the spleen was palpable below the costal margin. No shifting dullness or hepatic percussion tenderness was present, and bowel sounds were normal.
Laboratory examination revealed the following: (1) White blood cell count, 8.34 × 109/L; (2) Neutrophil count, 5.03 × 109/L; (3) Red blood cell count, 4.87 × 1012/L; (4) Hemoglobin, 135 g/L; (5) Platelet count, 180 × 109/L; (6) Alanine aminotransferase, 11.8 IU/L; (7) Aspartate aminotransferase, 16.0 IU/L; (8) Total bilirubin, 8.4 μmol/L; (9) Direct bilirubin, 1.4 μmol/L; (10) Albumin, 39.0 g/L; (11) Creatinine, 50 μmol/L; (12) Uric acid, 391.1 μmol/L; (13) Prothrombin time, 12.4 seconds; (14) International normalized ratio, 0.94; (15) Fibrinogen, 4.86 g/L; (16) Alpha-fetoprotein, 3.12 ng/mL; and (17) Carbohydrate antigen 19-9, 4.61 U/mL. Serologic tests for hepatitis B and C virus infections were negative.
Contrast-enhanced computed tomography (CT) was performed on January 31, 2023, using a GE Revolution 256-row CT system (GE Healthcare) with a 5.0-mm slice thickness. The results demonstrated a 6.2 cm × 4.2 cm well-circumscribed, oval, mixed-density mass in the right hepatic lobe and right adrenal region (Figure 1A and B). A large macroscopic fat component was present, and the nonfat component showed mild enhancement. The lesion was partly demarcated from the right adrenal gland, and the imaging report favored a hepatic origin. Iobitridol (300 mg iodine/mL) was used for contrast enhancement. The initial CT diagnosis was hepatic angiomyolipoma.
Magnetic resonance imaging (MRI) (Figure 1C and D) was performed on February 4, 2023, using a 1.5-T SIGNA Voyager system (GE Healthcare). The findings showed a 6.3 cm × 4.1 cm well-defined, oval mass in the right hepatic lobe. Axial T1-weighted LAVA-Flex imaging (Figure 1C) was obtained with a repetition time/echo time of 6.18/3.13 milliseconds, and a slice thickness of 4.6 mm. Axial fat-suppressed T2-weighted PROPELLER imaging (Figure 1D) was obtained with a repetition time/echo time of 3333.34/86.35 milliseconds, and a slice thickness of 5.0 mm. In-phase and opposed-phase imaging demonstrated marked signal loss and a peripheral chemical-shift boundary, confirming a substantial fat component. The lesion showed mild delayed enhancement and was hypointense during the hepatobiliary phase. Gadoxetate disodium was administered, but the exact dose was unavailable. The MRI diagnosis was hepatic angiomyolipoma.
Three-dimensional reconstructed images of the liver and adrenal glands (Figure 2) showed that the mass was located between the lower edge of the right lobe of the liver and the right adrenal gland. The mass was partially demarcated from the liver and clearly separated from the adrenal gland.
Postoperative histopathological findings supported a diagnosis of ectopic adrenal myelolipoma at the hepatic-adrenal interface. Gross examination showed a 6.0 cm × 4.5 cm × 3.5 cm soft, gray-red tumor beneath the hepatic capsule. Microscopically (Figure 3), hepatic tissue was present outside the tumor capsule, whereas mature adipose and hema
Because the patient was symptomatic and the lesion measured more than 6 cm, surgical resection was selected rather than observation. On February 10, 2023, laparoscopic local resection of the right posterior liver segment was performed. Intraoperatively, the lesion measured approximately 6 cm × 4 cm and was located in segment VII. The lesion was resected with approximately 2 cm of surrounding liver tissue. No blood transfusion was required.
The postoperative course was uncomplicated. Right upper abdominal pain improved, and no new symptoms developed. The patient was discharged on February 17, 2023, postoperative day 7, with satisfactory wound healing and no significant abnormalities on discharge assessment. Follow-up was conducted primarily by telephone until September 2024, providing a total follow-up duration of 19 months. Ultrasonography performed more than 1 month after surgery showed no evidence of recurrence. At the last follow-up, the patient had a good quality of life, no postoperative complications, and no documented tumor recurrence. The major clinical events, including imaging examinations, surgical treatment, postoperative recovery, and follow-up, are summarized in Table 1.
| Date | Clinical event |
| January 31, 2023 | The patient was admitted for evaluation of intermittent right upper abdominal pain. Contrast-enhanced computed tomography identified a 6.2 cm × 4.2 cm fat-containing mass near the right hepatic lobe and right adrenal gland; hepatic angiomyolipoma was suspected |
| February 4, 2023 | MRI confirmed a fat-containing lesion with mild delayed enhancement and hepatobiliary-phase hypointensity; three-dimensional reconstruction was employed to clarify the hepatic-adrenal relationship |
| February 10, 2023 | Laparoscopic local resection of the right posterior liver was performed |
| February 17, 2023 | The patient was discharged on postoperative day 7 after an uncomplicated recovery |
| March 28, 2023 | According to the available follow-up record, ultrasonography showed no obvious tumor recurrence |
| September 2024 | At the 19-month follow-up, the patient showed improved abdominal pain, good quality of life, and no documented recurrence or postoperative complications |
This case describes an ectopic adrenal myelolipoma at the hepatic–adrenal interface that involved the liver. Since myelolipoma consists of a large amount of mature adipose tissue and extramedullary hematopoietic components in different ratios[5,6], there is no characteristic imaging manifestation with different densities within the tumor and different signal intensities demonstrated on imaging. Therefore, HM is often misdiagnosed as other benign masses in clinical practice. Considering these factors, HM often needs to be differentiated from other benign liver tumors, especially hepatic angiomyolipoma. In the present case, the patient’s preoperative imaging was incorrectly reported as a hepatic angiomyolipoma. HM showed mixed density on enhanced CT, with the myeloid tissue showing high-density patches or cords, and varying degrees of enhancement, while the adipose tissue showed no enhancement. On MRI, the adipose component of HM showed a hyperintense signal on both T1-weighted and T2-weighted images, with no enhancement of the adipose tissue, while the myeloid tissue was isointense on T1-weighted images and hyperintense on T2-weighted images, with mild-to-moderate enhancement[7,8]. In terms of its histopathology, hepatic angiomyolipoma may also exhibit striations, nodules, and heterogeneous enhancement; therefore, the two entities can be difficult to distinguish radiologically[9,10].
Considering that the anterior-superior part of the right adrenal gland has no peritoneal coverage and is directly adjacent to the bare area of the liver, the pathogenesis of HM may be related to adrenal ectasia, adrenal myelolipoma ectasia, or hepatocellular metaplasia[1,11]. In the present case, an ectopic adrenal origin of the HM was favored for several reasons. First, the preoperative three-dimensional reconstruction images showed distinct boundaries between the liver and adrenal gland, suggesting that there was no ectasia or fusion between the two normal tissues. Second, postoperative histopathological examination showed a small amount of adrenal tissue in the envelope of the tightly adherent mass, while hepatic tissue was observed outside the tumor envelope, suggesting that the lesion arose from ectopic adrenal tissue or hepatocellular metaplasia. HM has also been shown to be associated with dietary and lifestyle factors, obesity, and endocrine disorders[12].
Currently, there is no consensus regarding the surgical management of hepatic angiomyolipoma. Surgical resection is recommended when the tumor is > 5 cm in diameter, progressively enlarging, or causing clinically significant symptoms[13,14]. Asymptomatic myelolipomas measuring ≤ 4 cm may be monitored regularly, whereas tumors > 4 cm are generally considered for surgical resection[15,16]. In this patient, right upper quadrant abdominal pain and a maximum tumor diameter of 6.2 cm supported surgical treatment, irrespective of whether the preoperative diagnosis was hepatic angiomyolipoma or HM. The patient recovered without complications and remained clinically well throughout 19 months of follow-up.
Several limitations of this report should be acknowledged. Neither special histochemical stains nor immunohistochemical staining for markers such as HMB-45, Melan-A, smooth muscle actin, cytokeratin, and CD68 was performed, and additional testing was not possible. Therefore, hepatic angiomyolipoma was considered unlikely based on hematoxylin and eosin morphology, the absence of an identifiable smooth muscle or epithelioid component, and the characteristic spatial distribution of adrenal and hepatic tissues. In addition, the archived imaging records did not include the exact CT contrast volume, injection rate, phase acquisition times, MRI contrast dose, or complete diffusion-weighted imaging parameters. Moreover, follow-up was conducted mainly by telephone. These limitations should be considered when interpreting the diagnostic certainty and long-term outcome.
Ectopic adrenal myelolipoma should be included in the differential diagnosis of fat-containing lesions at the hepatic-adrenal interface. Three-dimensional reconstruction can clarify the anatomical origin, but definitive diagnosis depends primarily on careful histopathological evaluation. Recognition of this rare entity may reduce preoperative misclassification and support appropriate surgical planning.
| 1. | Watanabe H, Murakami K, Motoi T, Murakami K, Aoyama Y, Mitomo H, Ishibashi N, Sugawara T, Tabata T, Matsuura T, Sasano H, Nakamura Y. Novel detection of the CAMTA1-WWTR1 fusion gene in extra-adrenal myelolipoma-like lesion: a case report. Virchows Arch. 2022;480:707-712. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 2. | Yildiz SM, Krombach GA, Roller FC. [Myelolipoma: A rare but important differential diagnosis of accidentally detected fatty retroperitoneal and adrenal masses]. Rofo. 2022;194:7-10. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 3. | Guillaume L, Vander Borght T, Bertrand C, Dupont M, Krug B. Presacral Myelolipoma: The Usefulness of a 99mTc-Albumin Nanocolloid Scintigraphy. Clin Nucl Med. 2021;46:38-39. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 4. | Morris PD, P'Ng C, Pleass H. Unique case of metachronous adrenal and hepatic myelolipomas. BMJ Case Rep. 2021;14:e240894. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 5. | Chang L, Yu D, Wang F. 17α-hydroxylase deficiency associated with adrenal myelolipoma. Pol Arch Intern Med. 2023;133:16369. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
| 6. | Erickson LA. Adrenal Myelolipoma. Mayo Clin Proc. 2021;96:3186-3187. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 3] [Reference Citation Analysis (0)] |
| 7. | Calissendorff J, Juhlin CC, Sundin A, Bancos I, Falhammar H. Adrenal myelolipomas. Lancet Diabetes Endocrinol. 2021;9:767-775. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 20] [Cited by in RCA: 87] [Article Influence: 17.4] [Reference Citation Analysis (0)] |
| 8. | Vigutto G, Lauro A, Vaccari S, Pirini MG, Diegoli M, D'Andrea V, Marino IR, Cervellera M, Tonini V. Giant Retroperitoneal Myelolipoma: An Unusual Diagnostic GI Challenge-Case Report and Review of the Literature. Dig Dis Sci. 2019;64:3431-3435. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 5] [Cited by in RCA: 4] [Article Influence: 0.6] [Reference Citation Analysis (1)] |
| 9. | AlSaffar AH, AlEssa AM, AlSharkawy T, Alamoudi NB, Makhdom FA. Anterior Mediastinal Myelolipoma: A Case Report and Review of the Literature. Am J Case Rep. 2022;23:e936005. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 9] [Article Influence: 2.3] [Reference Citation Analysis (0)] |
| 10. | Qin DA, Ren XQ, Zheng S, Bi H. An unusual diagnosis of paravertebral lesions: mediastinal myelolipoma. J Int Med Res. 2020;48:300060520936972. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 4] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 11. | Li KY, Wei AL, Li A. Primary hepatic myelolipoma: A case report and review of the literature. World J Clin Cases. 2020;8:4615-4623. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 7] [Cited by in RCA: 7] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
| 12. | Xu SY, Xie HY, Zhou L, Zheng SS, Wang WL. Synchronous occurrence of a hepatic myelolipoma and two hepatocellular carcinomas. World J Gastroenterol. 2016;22:9654-9660. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 8] [Cited by in RCA: 8] [Article Influence: 0.8] [Reference Citation Analysis (0)] |
| 13. | Cai X, Sun S, Deng Y, Liu J, Pan S. Hepatic epithelioid angiomyolipoma is scattered and unsuitable for surgery: a case report. J Int Med Res. 2023;51:3000605231154657. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 7] [Reference Citation Analysis (2)] |
| 14. | Fejes Z, Sánta F, Jenei A, Király IE, Varga L, Kuthi L. Angiomyolipoma of the kidney-Clinicopathological analysis of 52 cases. Pathol Oncol Res. 2022;28:1610831. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 15] [Reference Citation Analysis (0)] |
| 15. | Pokrovskaya A, Tarzimanova A, Vetluzhskaya M, Podzolkov V. Rare case of symptomatic adrenal myelolipoma. BMJ Case Rep. 2021;14:e245181. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 3] [Article Influence: 0.6] [Reference Citation Analysis (0)] |
| 16. | Andriandi, Cleven AHG, Hanff DF, Hartgrink H, Dijkstra PDS. Presacral myelolipoma, case report and literature review. Ann Med Surg (Lond). 2020;57:274-280. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 6] [Cited by in RCA: 8] [Article Influence: 1.3] [Reference Citation Analysis (0)] |